Hakutulokset - Urruticoechea, Ander

Evaluating the clinical effectiveness and safety of various HER2-targeted regimens after prior taxane/trastuzumab in patients with previously treated, unresectable, or metastatic H... Tekijä Paracha, Noman, Reyes, Adriana, Diéras, Véronique, Krop, Ian, Pivot, Xavier, Urruticoechea, Ander

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Integrative analysis of a cancer somatic mutome Tekijä Hernández, Pilar, Solé, Xavier, Valls, Joan, Moreno, Víctor, Capellá, Gabriel, Urruticoechea, Ander, Pujana, Miguel Angel

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Genetic interactions: the missing links for a better understanding of cancer susceptibility, progression and treatment Tekijä Maxwell, Christopher A, Moreno, Víctor, Solé, Xavier, Gómez, Laia, Hernández, Pilar, Urruticoechea, Ander, Pujana, Miguel Angel

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Altered Red Blood Cell Membrane Fatty Acid Profile in Cancer Patients Tekijä Amézaga, Javier, Arranz, Sara, Urruticoechea, Ander, Ugartemendia, Gurutze, Larraioz, Aitziber, Louka, Maria, Uriarte, Matxalen, Ferreri, Carla, Tueros, Itziar

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Altered Levels of Desaturation and ω-6 Fatty Acids in Breast Cancer Patients’ Red Blood Cell Membranes Tekijä Amézaga, Javier, Ugartemendia, Gurutze, Larraioz, Aitziber, Bretaña, Nerea, Iruretagoyena, Aizpea, Camba, Joana, Urruticoechea, Ander, Ferreri, Carla, Tueros, Itziar

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: Utility of transcriptome analysis of the autophagy interactome to guide b... Tekijä Cufí, Sílvia, Vazquez-Martin, Alejandro, Oliveras-Ferraros, Cristina, Corominas-Faja, Bruna, Urruticoechea, Ander, Martin-Castillo, Begoña, Menendez, Javier A.

Hae kokoteksti Hae kokoteksti

A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines Tekijä Puig, Teresa, Aguilar, Helena, Cufí, Sílvia, Oliveras, Glòria, Turrado, Carlos, Ortega-Gutiérrez, Sílvia, Benhamú, Bellinda, López-Rodríguez, María Luz, Urruticoechea, Ander, Colomer, Ramon

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Basal/HER2 breast carcinomas: Integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin) Tekijä Martin-Castillo, Begoña, Oliveras-Ferraros, Cristina, Vazquez-Martin, Alejandro, Cufí, Silvia, Moreno, José Manuel, Corominas-Faja, Bruna, Urruticoechea, Ander, Martín, Ángel G., López-Bonet, Eugeni, Menendez, Javier A.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Molecular response to aromatase inhibitor treatment in primary breast cancer Tekijä Mackay, Alan, Urruticoechea, Ander, Dixon, J Michael, Dexter, Tim, Fenwick, Kerry, Ashworth, Alan, Drury, Suzanne, Larionov, Alexey, Young, Oliver, White, Sharon, Miller, William R, Evans, Dean B, Dowsett, Mitch

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Predictive and Prognostic Brain Metastases Assessment in Luminal Breast Cancer Patients: FN14 and GRP94 from Diagnosis to Prophylaxis Tekijä Martínez-Aranda, Antonio, Hernández, Vanessa, Moreno, Ferran, Baixeras, Núria, Cuadras, Daniel, Urruticoechea, Ander, Gil-Gil, Miguel, Vidal, Noemí, Andreu, Xavier, Seguí, Miquel A., Ballester, Rosa, Castella, Eva, Sierra, Angels

Hae kokoteksti Hae kokoteksti Hae kokoteksti

A phase I study of the SRC kinase inhibitor dasatinib with trastuzumab and paclitaxel as first line therapy for patients with HER2-overexpressing advanced breast cancer. GEICAM/201... Tekijä Ocana, Alberto, Gil-Martin, Marta, Martín, Miguel, Rojo, Federico, Antolín, Silvia, Guerrero, Ángel, Trigo, José Manuel, Muñoz, Montse, Pandiella, Atanasio, Diego, Núria Gonzalo, Bezares, Susana, Caballero, Rosalía, Carrasco, Eva, Urruticoechea, Ander

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Discovery and Proof-of-Concept Study of Nuclease Activity as a Novel Biomarker for Breast Cancer Tumors Tekijä Hernandez, Luiza I., Araúzo-Bravo, Marcos J., Gerovska, Daniela, Solaun, Ricardo Rezola, Machado, Isabel, Balian, Alien, Botero, Juliana, Jiménez, Tania, Zuriarrain Bergara, Olaia, Larburu Gurruchaga, Lide, Urruticoechea, Ander, Hernandez, Frank J.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Biological Convergence of Cancer Signatures Tekijä Solé, Xavier, Bonifaci, Núria, López-Bigas, Núria, Berenguer, Antoni, Hernández, Pilar, Reina, Oscar, Maxwell, Christopher A., Aguilar, Helena, Urruticoechea, Ander, de Sanjosé, Silvia, Comellas, Francesc, Capellá, Gabriel, Moreno, Víctor, Pujana, Miguel Angel

Hae kokoteksti Hae kokoteksti Hae kokoteksti

FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies Tekijä Martínez-Aranda, Antonio, Hernández, Vanessa, Guney, Emre, Muixí, Laia, Foj, Ruben, Baixeras, Núria, Cuadras, Daniel, Moreno, Víctor, Urruticoechea, Ander, Gil, Miguel, Oliva, Baldo, Moreno, Ferran, González-Suarez, Eva, Vidal, Noemí, Andreu, Xavier, Seguí, Miquel A., Ballester, Rosa, Castella, Eva, Sierra, Angels

Hae kokoteksti Hae kokoteksti

Spatial intratumoural heterogeneity in the expression of GIT1 is associated with poor prognostic outcome in oestrogen receptor positive breast cancer patients with synchronous lymp... Tekijä Goicoechea, Ibai, Rezola, Ricardo, Arestin, María, Caffarel, María M., Cortazar, Ana Rosa, Manterola, Lorea, Fernandez-Mercado, Marta, Armesto, María, Sole, Carla, Larrea, Erika, Araujo, Angela M., Ancizar, Nerea, Plazaola, Arrate, Urruticoechea, Ander, Carracedo, Arkaitz, Ruiz, Irune, Alvarez Lopez, Isabel, Lawrie, Charles H.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

The Urinary Transcriptome as a Source of Biomarkers for Prostate Cancer Tekijä Solé, Carla, Goicoechea, Ibai, Goñi, Alai, Schramm, Maike, Armesto, María, Arestin, María, Manterola, Lorea, Tellaetxe, Maitena, Alberdi, Aitor, Nogueira, Leonor, Roumiguie, Mathieu, López, Jose Ignacio, Sanz Jaka, Juan Pablo, Urruticoechea, Ander, Vergara, Itziar, Loizaga-Iriarte, Ana, Unda, Miguel, Carracedo, Arkaitz, Malavaud, Bernard, Lawrie, Charles H.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population Tekijä Gómez-Miragaya, Jorge, Palafox, Marta, Paré, Laia, Yoldi, Guillermo, Ferrer, Irene, Vila, Sergi, Galván, Patricia, Pellegrini, Pasquale, Pérez-Montoyo, Hector, Igea, Ana, Muñoz, Purificación, Esteller, Manel, Nebreda, Angel R., Urruticoechea, Ander, Morilla, Idoia, Pernas, Sonia, Climent, Fina, Soler-Monso, María Teresa, Petit, Ana, Serra, Violeta, Prat, Aleix, González-Suárez, Eva

Hae kokoteksti Hae kokoteksti Hae kokoteksti

A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer Tekijä Pascual, Tomás, Martin, Miguel, Fernández-Martínez, Aranzazu, Paré, Laia, Alba, Emilio, Rodríguez-Lescure, Álvaro, Perrone, Giuseppe, Cortés, Javier, Morales, Serafín, Lluch, Ana, Urruticoechea, Ander, González-Farré, Blanca, Galván, Patricia, Jares, Pedro, Rodriguez, Adela, Chic, Nuria, Righi, Daniela, Cejalvo, Juan Miguel, Tonini, Giuseppe, Adamo, Barbara, Vidal, Maria, Villagrasa, Patricia, Muñoz, Montserrat, Prat, Aleix

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Design of a multinational randomized controlled trial to assess the effects of structured and individualized exercise in patients with metastatic breast cancer on fatigue and quali... Tekijä Hiensch, Anouk E., Monninkhof, Evelyn M., Schmidt, Martina E., Zopf, Eva M., Bolam, Kate A., Aaronson, Neil K., Belloso, Jon, Bloch, Wilhelm, Clauss, Dorothea, Depenbusch, Johanna, Lachowicz, Milena, Pelaez, Mireia, Rundqvist, Helene, Senkus, Elzbieta, Stuiver, Martijn M., Trevaskis, Mark, Urruticoechea, Ander, Rosenberger, Friederike, van der Wall, Elsken, de Wit, G. Ardine, Zimmer, Philipp, Wengström, Yvonne, Steindorf, Karen, May, Anne M.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment Tekijä Araujo, Angela M., Abaurrea, Andrea, Azcoaga, Peio, López-Velazco, Joanna I., Manzano, Sara, Rodriguez, Javier, Rezola, Ricardo, Egia-Mendikute, Leire, Valdés-Mora, Fátima, Flores, Juana M., Jenkins, Liam, Pulido, Laura, Osorio-Querejeta, Iñaki, Fernández-Nogueira, Patricia, Ferrari, Nicola, Viera, Cristina, Martín-Martín, Natalia, Tzankov, Alexandar, Eppenberger-Castori, Serenella, Alvarez-Lopez, Isabel, Urruticoechea, Ander, Bragado, Paloma, Coleman, Nicholas, Palazón, Asís, Carracedo, Arkaitz, Gallego-Ortega, David, Calvo, Fernando, Isacke, Clare M., Caffarel, María M., Lawrie, Charles H.

Hae kokoteksti Hae kokoteksti Hae kokoteksti